Login Register Cart 0
Generic placeholder image

Current Medical Imaging

Editor-in-Chief

ISSN (Print): 1573-4056
ISSN (Online): 1875-6603

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

Preoperative US Integrated Random Forest Model for Predicting Delphian Lymph Node Metastasis in Patients with Papillary Thyroid Cancer

Author(s): Chao Zhou, Chaoli Xu, Bin Yang, Zheng Zhu*, Yan Huang, Bo Shen, Xueming Dong, Xinyan Xu and Guotao Liu

Volume 19, Issue 9, 2023

Published on: 13 January, 2023

Article ID: e050123212397 Pages: 10

DOI: 10.2174/1573405619666230105150219

Price: $65

Abstract

Background: Delphian lymph node (DLN) has been considered to be a gate that predicts widespread lymph node involvement, higher recurrence and mortality rates of head and neck cancer.

Objective: This study aimed to establish a preoperative ultrasonography integrated machine learning prediction model to predict Delphian lymph node metastasis (DLNM) in patients with diagnosed papillary thyroid carcinoma (PTC).

Methods: Ultrasonographic and clinicopathologic variables of PTC patients from 2014 to 2021 were retrospectively analyzed. The risk factors associated with DLNM were identified and validated through a developed random forest (RF) algorithm model based on machine learning and a logistic regression (LR) model.

Results: A total of 316 patients with 402 thyroid lesions were enrolled for the training dataset and 280 patients with 341 lesions for the validation dataset, with 170 (28.52%) patients developed DLNM. The elastography score of ultrasonography, central lymph node metastasis, lateral lymph node metastasis, and serum calcitonin were predictive factors for DLNM in both models. The RF model has better predictive performance in the training dataset and validation dataset (AUC: 0.957 vs. 0.890) than that in the LR model (AUC: 0.908 vs. 0.833).

Conclusion: The preoperative ultrasonography integrated RF model constructed in this study could accurately predict DLNM in PTC patients, which may provide clinicians with more personalized clinical decision-making recommendations preoperatively. Machine learning technology has the potential to improve the development of DLNM prediction models in PTC patients.

Graphical Abstract

[1]
Isaacs JD, Lundgren CI, Sidhu SB, Sywak MS, Edhouse PJ, Delbridge LW. The Delphian lymph node in thyroid cancer. Ann Surg 2008; 247(3): 477-82.
[http://dx.doi.org/10.1097/SLA.0b013e31815efdc4] [PMID: 18376193]
[2]
Iyer NG, Kumar A, Nixon IJ, et al. Incidence and significance of Delphian node metastasis in papillary thyroid cancer. Ann Surg 2011; 253(5): 988-91.
[http://dx.doi.org/10.1097/SLA.0b013e31821219ca] [PMID: 21372688]
[3]
Chai YJ, Kim S, Choi JY, Koo DH, Lee KE, Youn YK. Papillary thyroid carcinoma located in the isthmus or upper third is associated with Delphian lymph node metastasis. World J Surg 2014; 38(6): 1306-11.
[http://dx.doi.org/10.1007/s00268-013-2406-x] [PMID: 24366273]
[4]
Tan Z, Ge MH, Zheng CM, Wang QL, Nie XL, Jiang LH. The significance of Delphian lymph node in papillary thyroid cancer. Asia Pac J Clin Oncol 2017; 13(5): e389-93.
[http://dx.doi.org/10.1111/ajco.12480] [PMID: 26990889]
[5]
Gong JX, Gu JW, Ji F, et al. Clinical Study on Prelaryngeal Lymph Node Metastasis in Papillary Thyroid Carcinoma. Cancer Manag Res 2020; 12: 1323-7.
[http://dx.doi.org/10.2147/CMAR.S232884] [PMID: 32110106]
[6]
Kim SY, Kim SM, Chang H, et al. Lateral neck metastases in the ipsilateral and contralateral compartments of papillary thyroid carcinoma located in one lobe. ANZ J Surg 2019; 89(11): E498-501.
[http://dx.doi.org/10.1111/ans.15458] [PMID: 31566299]
[7]
Resta L, Micheau C, Cimmino A. Prognostic value of the prelaryngeal node in laryngeal and hypopharyngeal carcinoma. Tumori 1985; 71(4): 361-5.
[http://dx.doi.org/10.1177/030089168507100407] [PMID: 4049538]
[8]
Li J, He G, Tong Y, et al. A novel scoring system for the risk of papillary thyroid cancer metastases in lymph nodes posterior to the right of the recurrent laryngeal nerve. Endocr Pract 2021; 27(1): 15-20.
[http://dx.doi.org/10.4158/EP-2020-0129] [PMID: 33471728]
[9]
Dy BM, Shaha AR, Tuttle RM. The delphian node revisited: An uncommon site of recurrence. J Endocr Soc 2017; 1(12): 1527-30.
[http://dx.doi.org/10.1210/js.2017-00333] [PMID: 29308446]
[10]
Haugen B R, Alexander E K, Bible K C, et al. 2015 American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: The American thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid 2016; 26(1): 1-133.
[11]
Yu J, Deng Y, Liu T, et al. Lymph node metastasis prediction of papillary thyroid carcinoma based on transfer learning radiomics. Nat Commun 2020; 11(1): 4807.
[http://dx.doi.org/10.1038/s41467-020-18497-3] [PMID: 32968067]
[12]
Giovagnorio F, Glorioso M, Di Brino M. Sonographic evaluation of anterior cervical lymph nodes. J Med Ultrason (2001) 2013; 40(3): 237-41.
[13]
Qi Q, Xu P, Zhang C, et al. Nomograms combining ultrasonic features with clinical and pathological features for estimation of delphian lymph node metastasis risk in papillary thyroid carcinoma. Front Oncol 2021; 11: 792347.
[http://dx.doi.org/10.3389/fonc.2021.792347] [PMID: 35004316]
[14]
American Institute of Ultrasound in Medicine. AIUM Practice Guideline for the performance of thyroid and parathyroid ultrasound examination. J Ultrasound Med 2003; 22(10): 1126-30.
[http://dx.doi.org/10.7863/jum.2003.22.10.1126] [PMID: 14606572]
[15]
Shiina T, Nightingale KR, Palmeri ML, et al. WFUMB guidelines and recommendations for clinical use of ultrasound elastography: Part 1: Basic principles and terminology. Ultrasound Med Biol 2015; 41(5): 1126-47.
[http://dx.doi.org/10.1016/j.ultrasmedbio.2015.03.009] [PMID: 25805059]
[16]
Tessler FN, Middleton WD, Grant EG, et al. ACR Thyroid Imaging, Reporting and Data System (TI-RADS): White Paper of the ACR TI-RADS Committee. J Am Coll Radiol 2017; 14(5): 587-95.
[http://dx.doi.org/10.1016/j.jacr.2017.01.046] [PMID: 28372962]
[17]
Li X, Duan Y, Liu D, et al. Diagnostic Model Incorporating Clinicopathological Characteristics of Delphian Lymph Node Metastasis Risk Profiles in Papillary Thyroid Cancer. Front Endocrinol (Lausanne) 2021; 12: 591015.
[http://dx.doi.org/10.3389/fendo.2021.591015] [PMID: 33841323]
[18]
Kim DH, Kim SW, Hwang SH. Predictive Value of Delphian Lymph Node Metastasis in the Thyroid Cancer. Laryngoscope 2021; 131(9): 1990-6.
[http://dx.doi.org/10.1002/lary.29426] [PMID: 33493364]
[19]
Olsen KD, Desanto LW, Pearson BW. Positive Delphian lymph node: Clinical significance in laryngeal cancer. Laryngoscope 1987; 97(9): 1033-7.
[http://dx.doi.org/10.1288/00005537-198709000-00007] [PMID: 3626727]
[20]
Wang B, Wen X, Zhang W, Qiu M. Clinical implications of Delphian lymph node metastasis in papillary thyroid carcinoma: A single-institution study, systemic review and meta-analysis. J Otolaryngol Head Neck Surg 2019; 48(1): 42.
[http://dx.doi.org/10.1186/s40463-019-0362-7] [PMID: 31470907]
[21]
Oh EM, Chung YS, Lee YD. Clinical significance of Delphian lymph node metastasis in papillary thyroid carcinoma. World J Surg 2013; 37(11): 2594-9.
[http://dx.doi.org/10.1007/s00268-013-2157-8] [PMID: 23877804]
[22]
Zheng G, Zhang H, Hao S, et al. Patterns and clinical significance of cervical lymph node metastasis in papillary thyroid cancer patients with Delphian lymph node metastasis. Oncotarget 2017; 8(34): 57089-98.
[http://dx.doi.org/10.18632/oncotarget.19047] [PMID: 28915656]
[23]
Kim WW, Yang SI, Kim JH, Choi YS, Park YH, Kwon SK. Experience and analysis of Delphian lymph node metastasis in patients with papillary thyroid carcinoma. World J Surg Oncol 2012; 10(1): 226.
[http://dx.doi.org/10.1186/1477-7819-10-226] [PMID: 23110552]
[24]
Kartal K, Aygün N, Uludağ M. Clinicopathologic Differences Between Micropapillary and Papillary Thyroid Carcinoma. Sisli Etfal Hastan Tip Bul 2019; 53(2): 120-4.
[PMID: 32377069]
[25]
Zhao H, Li H. Meta-analysis of ultrasound for cervical lymph nodes in papillary thyroid cancer: Diagnosis of central and lateral compartment nodal metastases. Eur J Radiol 2019; 112: 14-21.
[http://dx.doi.org/10.1016/j.ejrad.2019.01.006] [PMID: 30777203]
[26]
Li Y, Wang Y, Wu Q, Hu B. Transforming Growth Factor β1 Could Influence Thyroid Nodule Elasticity and Also Improve Cervical Lymph Node Metastasis in Papillary Thyroid Carcinoma. Ultrasound Med Biol 2015; 41(11): 2866-72.
[http://dx.doi.org/10.1016/j.ultrasmedbio.2015.07.010] [PMID: 26306431]
[27]
Liu H, Wan J, Xu G, et al. Conventional US and 2-D Shear Wave Elastography of Virtual Touch Tissue Imaging Quantification: Correlation with Immunohistochemical Subtypes of Breast Cancer. Ultrasound Med Biol 2019; 45(10): 2612-22.
[http://dx.doi.org/10.1016/j.ultrasmedbio.2019.06.421] [PMID: 31371128]
[28]
Skalska-Vorbrodt J. Lymphography of the cervical lymphatic system. Pol Przegl Radiol Med Nukl 1972; 36(1): 129-33.
[PMID: 5012366]
[29]
Andrade M, Jacomo A. Anatomy of the human lymphatic system. Cancer Treat Res 2007; 135: 55-77.
[http://dx.doi.org/10.1007/978-0-387-69219-7_5] [PMID: 17953408]
[30]
Lang BHH, Lo CY, Chan WF, Lam KY, Wan KY. Staging systems for papillary thyroid carcinoma: A review and comparison. Ann Surg 2007; 245(3): 366-78.
[http://dx.doi.org/10.1097/01.sla.0000250445.92336.2a] [PMID: 17435543]
[31]
Shaha AR. TNM classification of thyroid carcinoma. World J Surg 2007; 31(5): 879-87.
[http://dx.doi.org/10.1007/s00268-006-0864-0] [PMID: 17308849]
[32]
Machens A, Dralle H. Biomarker-based risk stratification for previously untreated medullary thyroid cancer. J Clin Endocrinol Metab 2010; 95(6): 2655-63.
[http://dx.doi.org/10.1210/jc.2009-2368] [PMID: 20339026]
[33]
Ye L, Zhou X, Lu J, Wang Y, Xie X, Zhang J. Combining serum calcitonin, carcinoembryonic antigen, and neuron‐specific enolase to predict lateral lymph node metastasis in medullary thyroid carcinoma. J Clin Lab Anal 2020; 34(7): e23278.
[http://dx.doi.org/10.1002/jcla.23278] [PMID: 32141647]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy